Tradewind Bioscience, Inc.
Daly City, CA
- UEI
- F397FLYH4JH8
- CAGE
- 7QLH9
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 38 Morningside Dr, Daly City, CA 94015, USA
- Website
- tradewindbio.com
- Founded
- 2018
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a therapeutic monoclonal antibody against EGFL6, a mediator of tumor growth and metastasis | National Cancer Institute (NIH) | $1,213,860 |
Quick answers
Is Tradewind Bioscience, Inc. registered in SAM.gov?
Yes. Tradewind Bioscience, Inc.'s SAM.gov registration is active through December 15, 2026.
What is Tradewind Bioscience, Inc.'s most recent federal award?
Tradewind Bioscience, Inc.'s most recent federal grant award is Development of a therapeutic monoclonal antibody against EGFL6, a mediator of tumor growth and metastasis (R41CA250757), from National Cancer Institute (NIH), on April 20, 2021.
On GovTribe
See Tradewind Bioscience, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors